$0.9444
0.0444[4.93%]
Last update: 9:23AM Get Real Time Here
Enveric Biosciences
(NASDAQ:ENVB)Enveric Biosciences Stock (NASDAQ:ENVB), Analyst Ratings, Price Targets, Predictions
Enveric Biosciences Inc has a consensus price target of $4.36, established from looking at the 5 latest analyst ratings. The last 3 analyst ratings were released from HC Wainwright & Co., Alliance Global Partners, and Aegis Capital on January 30, 2024, June 1, 2022, and March 8, 2022. With an average price target of $3.82 between HC Wainwright & Co., Alliance Global Partners, and Aegis Capital, there's an implied 304.14% upside for Enveric Biosciences Inc from these 3 analyst ratings.
Analyst Firms Making Recommendations1
HC Wainwright & Co.
Alliance Global Partners
Aegis Capital
Maxim Group
1calculated from analyst ratings published within the last 3 years
Analyst Ratings for Enveric Biosciences
date | ticker | Buy Now | Company | Current price | Upside/Downside | Analyst Firm | Analyst & % Accurate | Price Target Change | Rating Change | Previous / Current Rating | Get Alert |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 01/30/2024 | ENVB | Buy Now | Enveric Biosciences | $0.94 | 958.87% | HC Wainwright & Co. | Vernon Bernardino | → $10 | Initiates | → Buy | Get Alert |
| 06/01/2022 | ENVB | Buy Now | Enveric Biosciences | $0.94 | 32.36% | Alliance Global Partners | James Molloy | → $62.5 | Initiates | → Buy | Get Alert |
| 03/08/2022 | ENVB | Buy Now | Enveric Biosciences | $0.94 | -78.82% | Aegis Capital | Nathan Weinstein | $350 → $10 | Downgrade | Buy → Hold | Get Alert |
| 07/08/2021 | ENVB | Buy Now | Enveric Biosciences | $0.94 | 641.21% | Aegis Capital | Nathan Weinstein | — | Initiates | → Buy | Get Alert |
| 06/28/2021 | ENVB | Buy Now | Enveric Biosciences | $0.94 | 535.32% | Maxim Group | Jason McCarthy | — | Initiates | → Buy | Get Alert |
FAQ
What is the target price for Enveric Biosciences (ENVB)?
The latest price target for Enveric Biosciences (NASDAQ: ENVB) was reported by HC Wainwright & Co. on January 30, 2024. The analyst firm set a price target for $10.00 expecting ENVB to rise to within 12 months (a possible 958.87% upside). 1 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Enveric Biosciences (ENVB)?
The latest analyst rating for Enveric Biosciences (NASDAQ: ENVB) was provided by HC Wainwright & Co., and Enveric Biosciences initiated their buy rating.
When was the last upgrade for Enveric Biosciences (ENVB)?
There is no last upgrade for Enveric Biosciences.
When was the last downgrade for Enveric Biosciences (ENVB)?
The last downgrade for Enveric Biosciences Inc happened on March 8, 2022 when Aegis Capital changed their price target from $7 to $0.2 for Enveric Biosciences Inc.
When is the next analyst rating going to be posted or updated for Enveric Biosciences (ENVB)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Enveric Biosciences, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Enveric Biosciences was filed on January 30, 2024 so you should expect the next rating to be made available sometime around January 30, 2025.
Is the Analyst Rating Enveric Biosciences (ENVB) correct?
While ratings are subjective and will change, the latest Enveric Biosciences (ENVB) rating was a initiated with a price target of $0.00 to $10.00. The current price Enveric Biosciences (ENVB) is trading at is $0.94, which is within the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.